A full list of publications can be found here.
Publications indexed in Pubmed are here.
Feel free to email me to obtain a copy of any of the papers below.
Peer-reviewed papers
Names of supervised students/trainees are underlined
Submitted
[126] Stannah J, Knight J, Sandfort T,
Laurent C, Otieno FO, Larmarange J, Coulaud PJ, Mudhune V, Hamilton E,
Cummings V, Spire B, Reynold D, Okall D, Dembélé Keita B,
Sagaon-Teyssier L, Panchia R, Dadabhai S, Boily MC, and Maheu-Giroux M
(2024). The effect of sexual and gender minority violence on depression,
hazardous drinking, condom use, and HIV acquisition: an individual
participant data meta-analyses of the CohMSM, HPTN 075, and Anza Mapema
cohort studies in Africa.
[125] Heitner J, Standsfield SE, Mitchell KM,
Doyle CM, Milwid RM, Moore M, Donnell DJ, Xia Y,
Maheu-Giroux M, Barnabas R, Boily MC, Dimitrov DT (2024).
Cost-effectiveness of leveraging long-acting injectable Cabotegravir to
expand PrEP coverage among men who have sex with men in two contrasting
North American cities.
[124] Allorant A, Kuchukhidze S,
Stannah J, Xia Y, Masuku SS, Ekanmian GK, Imai-Eaton JW,
Maheu-Giroux M (2024). Socio-demographic and geographic
disparities in HIV prevalence, HIV testing, and treatment coverage: an
analysis of 108 national household surveys in 33 African countries.
[123] Torres-Flores S, Flores Anato JL, He
JH, Portilla VG, Wu Y, Maheu-Giroux M, Racine É,
Wagner CE (2024). Evaluating COVID-19 vaccination policy in Québec
(Canada) using a data-driven dynamic transmission model.
[122] Xiu F, Doyle CM, Flores Anato
JL, Knight J, Wang L, Cox J, Grace D, Hart TA, Zhang T,
Skakoon-Sparling S, Dvorakova M, Shahin R, Sachdeva H, Lachowsky N,
Sbihi H, Darrell HS Tan, Irvine MA, Mishra M,
Maheu-Giroux M (2024). Impact of interventions on mpox
transmission during the 2022 outbreak in Canada: a mathematical modeling
study of three different cities. Pre-print here.
[121] Beall R, Flores Anato JL, D’Souza AG,
Velásquez García HA, Ma H, Yang F, Baral SD, Cabaj J, Cooper E, Hillmer
M, Hollis A, Janjua NZ, Katz K, Leal J, Maheu-Giroux M,
May ER, Malikov K, Mishra M, Moloney G, Williamson T (2024). A Canadian
multi-province study of COVID-19 vaccine coverage along area-level
social determinants in 2021.
[120] Stevens O, Anderson R, Sabin K, Arias Garcia
S, Fearon E, Manda K, Dikobe W, Crowell TA, Tally L, Mulenga L, Neena P,
Maheu-Giroux M, McIntyre A, Hladik W, Zhao J, Mahy M,
Imai-Eaton JW (2024). HIV prevalence in transgender populations and
cisgender men who have sex with men in sub-Saharan Africa 2010-2022: a
meta-analysis. Pre-print here.
[119] Wang S, Wang L, Baral SD, Moloney G, Johns J,
Huber C, Mistry J, Khan K, Rao A, Janjua N, Williamson T, Katz A, Ma H,
Maheu-Giroux M, Mishra S, and Kustra R (2024). Mobility
changes following COVID-19 stay-at-home policies varied by socioeconomic
measures: an observational study in Ontario, Canada. PLOS Global
Public Health 4(11):e0002926.
[118] Pickles M, Mountain E, Bhattacharjee P, Kioko J,
Musimbi J, Musyoki H, Gichangi P, Stannah J, Maheu-Giroux
M, Becker M, and Boily MC (2024). Assessing the potential
impact of violence on HIV among female sex workers in Mombasa, Kenya: a
mathematical modeling study. BMC Medicine 22:468.
[117] Stannah J, Flores Anato JL, Pickles
M, Larmarange J, Mitchell KM, Artenie A, Dumchev K, Niangoran S, Platt
L, Terris-Prestholt F, Singh A, Stone J, Vickerman P, Phillips A,
Johnson L, Maheu-Giroux M, and Boily MC (2024). From
conceptualising to modelling structural determinants and interventions
in HIV transmission dynamics models: a scoping review and methodological
framework for evidence-based analyses. BMC Medicine 22:404.
[116] Xia Y, Caya C, Morin V, Singh A, Serhir B,
Libman M, Goldfarb D, Wong W, Xiu F, Bélanger RE, Touchette J-S,
Yansouni C, and Maheu-Giroux M (2024). The
population-level impact of introducing rapid diagnostic tests on
syphilis transmission in Canadian Arctic communities - A mathematical
modeling study. The Lancet Regional Health - Americas
37:100845.
[115] Lu IJ, Silhol R, d’Elbée M, Boily MC, Soni
N, Ky-Zerbo O, Vauthier A, Simo Fosto A, Badiane K, Traoré MM,
Terris-Prestholt F, Larmarange J, Maheu-Giroux M, and
the ATLAS Team (2024). Cost-effectiveness of HIV self-testing among key
populations in Côte d’Ivoire, Mali, and Senegal. Journal of the
International AIDS Society 27(7):e26334.
[114] Kouassi AK, Simo Fotso A, Rouveau N,
Maheu-Giroux M, Boily MC, Silhol R, d’Elbée M, Vautier
A, Larmarange J, on behalf of the ATLAS team (2024). HIV self-testing
positivity rate and linkage to confirmatory testing and care: a
telephone survey in Côte d’Ivoire, Mali, and Senegal. Peer Community
Journal 4:e56.
[113] Sardinha L, Yüksel-Kaptanoğlu I,
Maheu-Giroux M, García-Moreno C (2024). Intimate
partner violence against adolescent girls: regional and national
prevalence estimates and associated country-level factors. The
Lancet Child and Adolescent Health 8(9):636-646.
[112] Stevens O, Sabin K, Anderson RL, Arias Garcia S,
Willis K, Rao A, McIntyre A, Fearon E, Grard E, Stewart-Brown A, Cowan
F, Stannah J, Degenhardt L, Zhao J, Hakim AJ, Rucinski K, Sathane
I, Boothe M, Atuhaire L, Nyasulu P, Maheu-Giroux M,
Platt L, Rice B, Hadlik W, Baral S, Mahy M, and Imai-Eaton JW (2024).
Population size, HIV prevalence, and antiretroviral therapy coverage
among key populations in sub-Saharan Africa: collation and synthesis of
survey data (2010-2023). The Lancet Global Health
12(9):e1400-e1412.
[111] Xia Y, Flores Anato JL, Colijn C,
Janjua N, Otterstatter M, Irvine N, Tyler Williamson, Varughese MB, Li
M, Osgood N, Earn DJD, Sander B, Cipriano LE, Murthy K, Xiu F, Godin
G, Buckeridge DL, Hurford H, Sharmistha Mishra S, and
Maheu-Giroux M (2024). Canada’s provincial COVID-19
pandemic modelling efforts: a review of mathematical models and their
impacts on the responses. Canadian Journal of Public Health
115(4):541-557.
[110] Silhol R, Maheu-Giroux M, Soni
N, Simo Fotso A, Rouveau N, Vautier A, Doumenc-Aïdara C, Geoffroy O,
N’Guessan KN, Younoussa S, Kabemba OK, Gueye PA, Dama Ndeye P,
Mukandavire C, Vickerman P, Keita A, Ndour CT, Ehui E, Larmarange J,
Boily MC, and the ATLAS Team (2024). The impact of past HIV
interventions and treatment gaps on new HIV acquisitions, transmissions,
and HIV-related deaths in Côte d’Ivoire, Mali, and Senegal.
AIDS 28(12):1783-1793.
[109] Kuchukhidze S, Walters M, Panagiotoglou D,
Boily MC, Diabaté S, Russel A, Stöckl H, Sardinha L, Mbofana F, Wanienze
RK, Imai-Eaton JW, and Maheu-Giroux M (2024). The
contribution of intimate partner violence to vertical HIV transmission:
a modeling analysis of 46 African countries. The Lancet HIV
11(8):e542-e551.
[108] Silhol R, Maheu-Giroux M, Soni
N, Simo Fotso A, Rouveau N, Vautier A, Doumenc-Aidara C, Geoffroy O,
N’Guessan KN, Sidibe Y, Kabemba OK, Gueye PA, Mukandavire C, Vickerman
P, Keita A, Ndour CT, Ehui E, Larmarange J, Boily MC, The ATLAS Team
(2024). Potential population-level effects of HIV self-testing
distribution among key populations in Côte d’Ivoire, Mali, and Senegal:
a mathematical modelling analysis. The Lancet HIV
11(8):e531-e541.
[107] Sardinha L, Stöckl H, Maheu-Giroux
M, Meyer SR, García-Moreno C (2024). Global prevalence of
non-partner sexual violence against women. Bulletin of the World
Health Organization 102(8):582-587.
[106] Levinsson A, Zolopa C, Vakili F, Udhesister S,
Kronfli N, Maheu-Giroux M, Bruneau J, Valerio H, Bajis
S, Read P, Matró E, Boucher L, Morris L, Grebely J, Artenie A, Stone J,
Vickerman P, Larney S (2024). Sex and gender differences in hepatitis C
virus risk, prevention, and cascade of care in people who inject drugs:
systematic review and meta-analysis. eClinical Medicine
72:102596.
[105] Juwono S, Flores Anato JL,
Kirschbaum A, Metheny N, Dvorakova M, Skakoon-Sparling S, Moore DM,
Grace D, Hart TA, Lambert G, Lawchosky NJ, Jollimore J, Cox J,
Maheu-Giroux M (2024). Prevalence, determinants, and
trends in the experience and perpetration of intimate partner violence
among a cohort of gay, bisexual, and other men who have sex with men in
Montréal, Toronto, and Vancouver, Canada (2017-2022). LGBT
Health. (Accepted)
[104] Maheu-Giroux M and Mishra S
(2024). Evidence with 95-95-95 that ambitious is feasible. The
Lancet HIV 11(4):e203-204.
[103] Xiu F+, Flores Anato JL+
(+contributed equally), Cox J, Grace D, Hart TA, Skakoon-Sparling S,
Dvorakova M, Knight J, Wang L, Gatalo, O, Campbell E, Zhang T, Sbihi H,
Irvine MA, Mishra S, Maheu-Giroux M (2024).
Characteristics of the sexual networks of gay, bisexual, and other men
who have sex with men in Montréal, Toronto, and Vancouver: implications
for the transmission and control of mpox in Canada. Journal of
Infectious Diseases 229(S2):S293–S304.
[102] Allorant A, Muset P, Hodgins
C, Kirakoya-Samadoulougou F, Namachapa K, Mbofana F, Panagiotoglou,
Johnson LF, Eaton JW, and Maheu-Giroux M (2024).
Temporal trends and determinants of HIV testing at antenatal care in
sub-Saharan Africa: a pooled analysis of population-based surveys
(2005-2021). JAIDS – Journal of Acquired Immune Deficiency
Syndromes 95(S1):E97-E105.
[101] Steven O, Anderson R, Stover J, Teng Y,
Stannah J, Silhol R, Jones H, Booton RD, Martin-Hughes R, Johnson
LF, Maheu-Giroux M, Mishra S, Stone J, Bershteyn A,
Sabin K, Mitchell KM, Dimitrov D, Baral S, Donnell D, Korenromp E, Rice
B, Hargreaves J, Vickerman P, Mahy M, Boily MC, Eaton JW (2024).
Comparison of empirically derived and model-based estimates of key
population HIV incidence and the distribution of new infections by
population group in sub-Saharan Africa. JAIDS – Journal of Acquired
Immune Deficiency Syndromes 95(S1):E46-E58.
[100] Silhol R, Anderson RL, Stevens O, Stannah
J, Booton RD, Baral S, Dimitrov D, Mitchell K, Donnell D, Bershteyn,
Brown T, Kelly SL, Kim HY, Johnson LF, Maheu-Giroux M,
Martin-Hugues R, Mishra S, Peerapatanapokin W, Stone J, Stover J, Stuart
R, Teng Y, Vickerman P, Wilson DP, Korenromp E, Eaton JW, Boily MC
(2024). Measuring HIV acquisitions among partners of key populations:
estimates from HIV transmission dynamic models. JAIDS – Journal of
Acquired Immune Deficiency Syndromes 95(S1):E59-E69.
[99] Boye S, Kouadio A, Kouvahe AF, Vautier A, Ky-Zerbo
O, Rouveau N, Maheu-Giroux M, Larmarange J, Pourette D,
and the ATLAS Team (2024). Organisation of testing services, structural
barriers and facilitators of routine HIV self-testing during sexually
transmitted infection consultations: a qualitative study of patients and
providers in Abidjan, Côte d’Ivoire. BMC Infectious Diseases
22(Suppl 1) 975.
[98] Doyle CM, Milwid RM, Cox J, Xia
Y, Lambert G, Tremblay C, Otis J, Boily MC, Baril JG, Mercure SA,
Thomas R, Trottier B, Mishra S, Maheu-Giroux M (2023).
Population-level impact of pre-exposure prophylaxis on HIV acquisitions
among men who have sex with men: a mathematical modeling study in
Montréal, Canada (2013-2021). Journal of the International AIDS
Society 26:e26194.
[97] Milwid RM, Li M, Fazil A,
Maheu-Giroux M, Doyle CM, Xia Y, Cox J,
Grace D, Dvorakova M, Walker SC, Mishra SM, Ogden NH (2023). Exploring
the dynamics of the 2022 mpox outbreak in Canada. Journal of Medical
Virology 95:e29256.
[96] Yokoji K, Giguère K, Malagón T, Rönn
MM, Mayaud P, Kelly H, Delany-Moretlwe S, Drolet M, Brisson M, Boily MC,
Maheu-Giroux M (2023). Association of naturally
acquired type-specific HPV antibodies and subsequent HPV re-detection:
Systematic review and meta-analysis. Infectious Agents and
Cancer 18:70.
[95] Kouassi Kra A, Simo Fosto A, N’guessan KN,
Geoffroy O, Younoussa S, Kabemba OK, Gueye PA, Ndeye PD, Rouveau N,
Maheu-Giroux M, Boily MC, Silhol R, d’Elbée M, Vautier
A, Larmarange J, and the ATLAS Team (2023). Can HIV self-testing reach
first-time testers? A telephone survey among self-test end users in Côte
d’Ivoire, Mali, and Senegal. BMC Infectious Diseases
22(S1):972.
[94] Kuchukhidze S, Panagiotoglou, Boily MC,
Diabaté s, Eaton JW, Stöckl H, Mbofana F, Wanyenze RK, and
Maheu-Giroux M (2023). Characteristics of male
perpetrators of intimate partner violence and implications for women’s
HIV status: a pooled analysis of cohabiting couples from sub-Saharan
Africa (2000-2020). PLOS Global Public Health 3(9):e0002146.
[93] Flores Anato JL, Ma H, Hamilton MA, Xia Y,
Harper S, Buckeridge D, Brisson M, Hillmer MP, Malikov K, Aidin Kerem,
Beall R, Baral S, Dubé È, Mishra S, Maheu-Giroux M
(2023). Impact of a vaccine passport on first-dose vaccine coverage by
age and area-level social determinants of health in the Canadian
provinces of Québec and Ontario: an interrupted time series analysis.
CMAJ Open 11(5):e955-e1005.
[92] Caya C, Singh AE, Serhir B, Morin V, Libman MD,
Corsini R, Goldfarb DM, Wong T, Xia Y, Maheu-Giroux
M, and Yansouni CP (2023). Rapid diagnostic testing for
syphilis in Arctic communities (the STAR study): A multisite prospective
field diagnostic accuracy study in an intended-use setting. Clinical
Microbiology and Infection 29(10):P1335.E1-1335.E7.
[91] Silhol R, Nordsletten A, Maheu-Giroux
M, Elmes J, Staunton R, Owen B, Shacklett B, McGowan I, Gomez
Feliciano K, van der Straten A, Eller LA, Robb M, Mararazzo J, Dimitrov
D, Boily MC (2023). The association between heterosexual anal
intercourse and HIV acquisition in three prospective cohorts of women.
AIDS and Behavior 27:4010-4021.
[90] Stansfield S, Heitner J, Mitchell K, Doyle
CM, Milwid R, Moore J, Donnell D, Hanscom B, Xia Y,
Maheu-Giroux M, Van de Vijver D, Wang H, Barnabas R,
Boily MC, Dimitrov D (2023). Population-level impact of expanding PrEP
coverage by offering long-acting injectable PrEP to MSM in three high
resources settings: a model comparison analysis. Journal of the
International AIDS Society 26(S2):e26109.
[89] Ky-Zerbo O, Desclaux A, Boye S,
Maheu-Giroux M, Rouveau N, Vautier A, Camara CS,
Kouadio BA, Sow S, Gueye PA, Geoffroy O, Kamemba OK, Ehui E, Ndour CT,
Keita A, Larmarange J, and the ATLAS Team (2023). “I take it and give it
to my partners who will give it to their partners”: Secondary
distribution of HIV self-tests (HIVST) by key populations in Côte
d’Ivoire, Mali, and Senegal. BMC Infectious Diseases 22:970.
[88] Stannah J, Soni R, Lam JKS, Giguère K,
Mitchell K, Kronfli N, Larmarange J, Moh R, N’zebo Nouaman M, Kouamé GM,
Boily MC, Maheu-Giroux M (2023). Trends in HIV testing,
the treatment cascade, and HIV incidence among men who have sex with men
in Africa: A systematic review and meta-analysis. The Lancet
HIV 10(8):e528-e542.
[87] Lanièce Delaunay C, Klein MB, Godin
A, Cox J, Kronfli N, Lebouché B, Doyle CM, Maheu-Giroux
M (2023). Public health interventions, priority populations,
and the impact of COVID-19 disruptions on hepatitis C elimination among
people who have injected drugs in Montreal (Canada): a modeling study.
International Journal of Drug Policy 116:104026.
[86] Yang L, Boily MC, Rönn MM, Obiri-Yeboah D,
Morhason-Bello I, Meda N, Lompo Olga, Mayaud P, Pickles M, Hodgins
C, Brisson M, Delany-Moretlwe S, Maheu-Giroux M
(2023). Regional and country-level trends in cervical cancer screening
coverage in sub-Saharan Africa: a systematic analysis of
population-based surveys (2000-2020). PLoS Medicine
20(1):e1004143.
[85] Kuchukhidze S, Panagiotoglou D, Boily MC,
Diabaté S, Eaton JW, Mbofana F, Sardinha L, Schrubbe L, Stöckl H,
Wanyenze R, and Maheu-Giroux M (2023). The effects of
intimate partner violence on women’s risk of HIV acquisition and
engagement in the HIV treatment and care cascade: a pooled analysis of
nationally representative surveys in sub-Saharan Africa. The Lancet
HIV 10(2):E107-E117.
[84] Kronfli N, Dussault C, Maheu-Giroux
M, Halavrezos A, Chalifoux S, Park Y, Del Balso L, Cheng MP,
Cox J (2022). Importance of occupation for SARS-CoV-2 seroprevalence and
COVID-19 vaccination among correctional workers in Quebec, Canada
(2021). Frontiers in Public Health 10:1021871.
[83] Caya C, Maheu-Giroux M, Xia
Y, Serhir B, Morin V, Corsini R, Goldfarb D, Wong T, Singh AE, and
Yansouni C (2022). Stopping syphilis transmission in Artic communities
through rapid diagnostic testing: the STAR study protocol. PLoS
One 17(9):e0273713.
[82] Doyle CM, Cox J, Milwid RM, Bitera
R, Lanièce Delaunay C, Alary M, Lambert G, Tremblay C, Mishra S, and
Maheu-Giroux M (2022). Measuring progress towards
reaching zero new HIV acquisitions among key populations in Québec
(Canada) using routine surveillance data: a mathematical modelling
study. Journal of the International AIDS Society 25:e25994.
[81] Staagdegaard L, Soni N, Bellerose M, Dala S, Bloem
P, Brisson M, Maheu-Giroux M, Barnabas R, Drolet M,
Mayaud P, Rönn MM, Boily MC (2022). Immunogenicity, safety, and efficacy
of the HPV vaccines in people living with HIV: a systematic review and
meta-analysis. eClinical Medicine 52:101585.
[80] Simo Fotso A, Johnson C, Vautier A, Kouamé KB,
Diop PM, Silhol R, Maheu-Giroux M, Boily MC, Rouveau N,
Doumenc-Aïdara S, Baggaley R, Ehui E, Larmarange J, and the ATLAS
Team (2022). Routine programmatic data show a positive
population-level impact of HIV self-testing: the case of Côte d’Ivoire
and implications for implementation. AIDS 36(13):1871-1879.
[79] Owen BN, Baggaley RF, Maheu-Giroux
M, Elmes J, Adimora AA, Ramirez C, Edmonds A, Sosanya K, Taylor
TT, Plankey M, Cederbaum JA, Seidman D, Weber KM, Golub ET, Wells J,
Bolivar H, Konkle-Parker D, Pregartner G, Boily MC (2022). Longitudinal
determinants of anal intercourse among women with, and without HIV in
the United States. BMC Women’s Health 22:291.
[78] Traore MM, Badiane (co-first author), Vautier A,
Fotso AS, Kabemba OK, Rouveau N, Maheu-Giroux M, Boily
MC, Larmarange J, Terris-Prestholt F, d’Elbée M, and the ATLAS Team
(2022). Economic analysis of low volume interventions using real-world
data: Costs of HIV self-testing distribution and HIV testing services in
west Africa from the ATLAS project. Frontiers in Health
Services 2:886513.
[77] Maheu-Giroux M, Sardinha L,
Stöckl H, Meyer S, Godin A, Alexander M, and García-Moreno C
(2022). A framework to model global, regional, and national estimates of
intimate partner violence. BMC Medical Research Methodology
22:159.
[76] Xia Y, Ma H, Buckeridge DL, Brisson M,
Sander B, Chan A, Verma A, Ganser I, Kronfli N, Mishra S,
Maheu-Giroux M (2022). Mortality trends and length of
stays among hospitalized COVID-19 patients in Ontario and Québec
(Canada): a cohort study of the first three epidemic waves. The
International Journal of Infectious Diseases 121:1-10.
[75] Ky-Zerbo O, Desclaux A, Boye S, Vautier A, Rouveau
N, Kouadio Brou A, Fotso Arlette S, Pourette D, Maheu-Giroux
M, Sow S, Camara CS, Clémence DA, Keita A, Boily MC, Silhol R,
D’elbée M, Bekelynck A, Gueye Papa A, Diop Papa M, Geoffroy O, Kamemba
Odé K, Diallo S, Ehui E, Ndour Cheick T, and Larmarange J for the
ATLAS Team (2022). Willingness to use and distribute HIV
self-test kits to clients and partners: a qualitative analysis of female
sex workers’ collective opinion and attitude in Côte d’Ivoire, Mali, and
Senegal. Women’s Health 18:1-11.
[74] Milwid R, Xia Y, Doyle C, Cox
J, Lambert G, Thomas R, Mishra S, Grace D, Lachowsky NJ, Hart TA, Boily
MC, and Maheu-Giroux M (2022). Past dynamics of HIV
transmission among men who have sex with men in Montréal, Canada: a
mathematical modeling study. BMC Infectious Diseases 22:233.
[73] Vickers DM, Bara SD, Mishra S, Kwong JC, Sundaram
M, Katz A, Calzavara A, Maheu-Giroux M, Buckeridge DL,
Williamson T (2022). Stringency of containment and closure policies and
their association with growth of SARS-CoV-2 cases in Canada prior to
accelerated vaccine roll-out. International Journal of Infectious
Diseases 118:73-82.
[72] Lanièce Delaunay C, Maheu-Giroux
M, Marathe G, Saeed S, Martel-Laferrière, Cooper CL, Walmsey S,
Cox J, Wong A, and Klein MB, for the Canadian Coinfection Cohort
Investigators (2022). Gaps in hepatitis C virus prevention and care
for HIV-hepatitis C virus co-infected people who injected drugs in
Canada. International Journal of Drug Policy 103:1-10.
[71] Kronfli N, Dussault C, Maheu-Giroux
M, Halavrezos A, Chalifoux S, Sherman J, Park H, Del Balso L,
Cheng MP, Poulin S, Cox J (2022). Seroprevalence and risk factors for
SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021): a
cross-sectional study. Clinical Infectious Diseases. (Accepted)
[70] Xia Y, Ma H, Moloney G, Velásquez García
HA, Sirski M, Janjua NZ, Vickers D, Williamson T, Katz A, Yu K, Kustra
R, Buckeridge DL, Brisson M, Baral SD, Mishra S, and
Maheu-Giroux M (2022). Geographical concentration of
SARS-CoV-2 cases by social determinants of health in metropolitan areas
in Canada: a cross-sectional study. Canadian Medical Association
Journal 194(6):E195-E204.
[69] Simo Fosto A, Kouassi Kra A, Maheu-Giroux
M, Boye S, d’Elbée M, Ky-Zerbo O, Rouveau N, N’Guessan NK,
Geoffroy O, Vautier A, Larmarange, the ATLAS Team (2022). Is it
possible to recruit HIV self-test users for an anonymous phone-based
survey using passive recruitment without financial incentives? Lessons
learned from a pilot study in Côte d’Ivoire. Pilot and Feasibility
Studies 8:4.
[68] Sardinha L, Maheu-Giroux M,
Stöckl H, Meyer S, García-Moreno C (2022). Global, regional, and
national prevalence of intimate partner violence against women (2018).
The Lancet 399(10327):803-813.
[67] Flores Anato JL, Panagiotoglou D, Greenwald
ZR, Blanchette M, Trottier C, Vaziri M, Charest L, Szabo J, Thomas R,
and Maheu-Giroux M (2022). Chemsex and incidence of
sexually transmitted infections among Canadian pre-exposure prophylaxis
(PrEP) users in the l’Actuel PrEP Cohort (2013-2020). Sexually
Transmitted Infections 98:549-556.
[66] Hodgins C, Stannah J, Kuchukhidze
S, Lycias Z, Eaton JW, Boily MC, Maheu-Giroux M
(2022). Population sizes, HIV prevalence, and HIV prevention among men
who paid for sex in sub-Saharan Africa: a meta-analysis of 87
population-based surveys (2000-2020). PLOS Medicine
19(1):e1003861.
[65] Panagiotoglou D, Abrahamowicz M, Buckeridge D,
Caro JJ, de Montigny L, Latimer EA, Maheu-Giroux M, and
Strumpf EC (2021). Evaluating Montréal’s harm reduction interventions
for people who inject drugs: protocol for observational study and
cost-effectiveness analysis. BMJ Open 11(10):e053191.
[64] Giguère K, Vaziri M, Olivier C, Charest L,
Szabo J, Thomas R, Maheu-Giroux M (2021).
Characteristics of new HIV diagnoses over 1983-2019: a clinic-based
study in Montréal (Canada). PLOS One 16(10):e0258383.
[63] Mitchell KM, Maheu-Giroux M,
Dimitrov D, Moor M, Hughes JP, Donnel D, Beyrer C, El-Sadr W, Cohen MS,
Boily MC (2021). How can progress toward Ending the HIV Epidemic in the
United States be monitored? Clinical Infectious Diseases
75(1):163-169.
[62] Ky-Zerbo O, Desclaux A, Brou Kouadio A, Rouveau R,
Vautier A, Sow S, Sidi Camara C, Boye S, Pourette D, Sidibe Y,
Maheu-Giroux M, Larmarange J, and the ATLAS
Team (2021). Enthusiasm for introducing and integrating HIV
self-testing but doubts about users: a baseline qualitative analysis of
key stakeholders’ attitudes and perceptions in Côte d’Ivoire, Senegal,
and Mali. Frontiers in Public Health 9:1525.
[61] Maheu-Giroux M, Ciaranello AL,
Salomon JA, Sohn AH (2021). Refining global HIV estimates for
decision-making: advances in analytic and modeling methods used by the
Joint United Nations Programme on HIV/AIDS. Journal of the
International AIDS Society 24(S5):e25790.
[60] Mishra S, Ma H, Moloney G, Yiu KCY, Darvin D,
Landsman D, Kwong JC, Calzavara A, Straus S, Chan AK, Gournis E, Rilkoff
H, Xia Y, Katz A, Williamson T, Malikov K, Kustra R,
Maheu-Giroux M, Sander B, Baral SD, and the COVID-19
Heterogeneity Research Group (2021). Increasing concentration of
COVID-19 by socioeconomic determinants and geography in Toronto, Canada:
an observational study. Annals of Epidemiology 65:84-92.
Finalist for the 2023 Best Paper Award.
[59] Godin A, Eaton JW, Giguère K, Marsh
K, Leigh J, Jahn A, Mbofana F, Ehui E, Maheu-Giroux M
(2021). Inferring population HIV incidence trends from surveillance data
of recent HIV infection among HIV testing clients. AIDS
35(14):2383-2388.
[58] Flores Anato JL, Panagiotoglou D, Greenwald
Z, Trottier T, Thomas R, Maheu-Giroux M (2021). Chemsex
practices and pre-exposure prophylaxis (PrEP) trajectories among
individuals consulting for PrEP at a large sexual health clinic in
Montréal, Canada (2013-2020). Drug and Alcohol Dependence
226:10887.
[57] Lanièce Delaunay C, Godin A, Kronfli
N, Panagiotoglou D, Cox J, Alary M, Klein M, and Maheu-Giroux
M (2021). Can hepatitis C elimination targets be sustained
among people who inject drugs post-2030? International Journal of
Drug Policy 96:103343.
[56] Duchesne L, Dussault C, Godin A,
Maheu-Giroux M, Kronfli N (2021). Implementing opt-out
Hepatitis C screening in Canadian provincial prisons: a model-based
cost-effectiveness study. International Journal of Drug Policy
96:103345.
[55] Soni N, Giguère K, Boily MC, Fogel JM,
Maheu-Giroux M, Dimitrov D, Eshleman SH, Mitchell KM
(2021). Under-reporting of known HIV-positive status among people living
with HIV: a systematic review and meta-analysis. AIDS and
Behavior 25(12):3858-3870.
[54] d’Elbée M, Traore MM, Badiane K, Vautier A, Simo
Fosto A, Kabemba OK, Rouveau N, Godfrey-Faussett P, Maheu-Giroux
M, Boily MC, Medley G, Larmarange J, Terris-Prestholt F, and
the ATLAS Team (2021). Preparing for sustainable scale-up:
economic analysis of HIV self-testing kits provision by civil society
organizations to key populations and their sexual partners in Côte
d’Ivoire, Senegal, and Mali. Frontiers in Public Health
(Accepted).
[53] Boye S, Bouaré S, Ky-Zerbo O, Rouveau N, Simo
Fotso A, d’Elbée M, Silhol S, Maheu-Giroux M, Vautier
A, Breton G, Keita A, Bekelynck A, Desclaux A, Larmarange J, Pourette D,
and the ATLAS Team (2021). Challenges of HIV self-test
distribution for index testing when HIV status disclosure is low: an
ethnographic study in Bamako (Mali) as part of the ATLAS project.
Frontiers in Public Health. Frontiers in Public Health
(Accepted).
[52] Stoeckl H, Sardinha L, Meyer S,
Maheu-Giroux M, and García-Moreno C (2021). Physical,
sexual and psychological intimate partner violence and non-partner
sexual violence against women and girls: a systematic review protocol
for producing global, regional and country estimates. BMJ Open
11:e045574.
[51] Silhol R, Geidelberg L, Mitchell KM, Mishra S,
Dimitrov D, Bowring A, Béhanzin L, Guédou F, Diabaté S, Schwartz S,
Billong SC, Njindam IM, Levitt D, Mukandavire C, Maheu-Giroux
M, Rönn MM, Dalal S, Vickerman P, Baral S, Alary M, Boily MC
(2021). Assessing the potential impact of disruptions due to COVID-19 on
HIV among key and lower-risk populations in the largest cities of
Cameroon and Benin. JAIDS – Journal of Acquired Immune Deficiency
Syndrome 87(3):899-911.
[50] Cox J, Apelian H, Moodie EEM, Messier-Peet M, Hart
TA, Grace D, Moore DM, Lachowsky NJ, Armstrong HL, Jollimore J,
Skakoon-Sparling S, Rodrigues R, Tan DHS, Maheu-Giroux
M, Noor SW, Lebouché B, Tremblay C, Olarewaju G, Lambert G, and
the Engage Study Team (2021). HIV pre-exposure prophylaxis (PrEP) use
among urban Canadian gay, bisexual and other men who have sex with men
for whom PrEP is clinically recommended: baseline results from the
Engage Cohort Study. CMAJ Open 9(2):E529-E538.
[49] Rouveau N, Ky-Zerbo O, Boye S, Simo Fotso A,
d’Elbée M, Maheu-Giroux M, Silhol R, Kra Kouassi A,
Vautier A, Doumenc-Aïdara C, Breton G, Keita A, Ehui E, Cheikh Tidiane
N, Boily MC, Terris-Prestholt F, Pourette D, Desclaux A, Larmarange J,
the ATLAS Team (2021). Describing, analysing and understanding
the effects of the introduction of HIV self-testing in West Africa
through the ATLAS programme in Côte d’Ivoire, Mali and Senegal. BMC
Public Health 21:181.
[48] Carabali M, Maheu-Giroux M,
Kaufman J (2021). Dengue, severity paradox and socioeconomic
distribution among Afro-Colombians. Epidemiology 32(4):541-550.
[47] Giguère K, Eaton JW, Marsh K, Johnson LF,
Johnson CC, Ehui E, Jahn A, Wanyeky I, Mbofana F, Bakiono F, Mahy M,
Maheu-Giroux M (2021). Trends in knowledge of HIV
status and efficiency of HIV testing services in sub-Saharan Africa
(2000-2020): a modelling study of survey and HIV testing program data.
The Lancet HIV 8(5):e284-293.
[46] Xia Y, Milwid RM, Godin A,
Boily MC, Johnson LF, Marsh K, Eaton JW, Maheu-Giroux M
(2021). Accuracy of self-reported HIV testing history and awareness of
HIV-positive status among people living with HIV in four sub-Saharan
Africa countries. AIDS 35(3):503-510.
[45] Godin A+, Xia Y+ (+ co-first
author), Buckeridge D, Mishra S, Douwes-Schultz D, Shen Y, Lavigne M,
Drolet M, Schmidt A, Brisson M, and Maheu-Giroux M
(2021). The role of case importation in explaining differences in early
SARS-CoV-2 transmission dynamics in Canada - a mathematical modeling
study of surveillance data. The International Journal of Infectious
Diseases 102:254-259.
[44] Zhao N, Charland K, Carabali M, Nsoesie E,
Maheu-Giroux M, Rees E, Yuan M, Balaguera CG, Jaramillo
Ramirez G, Zinszer K (2020). Machine learning and dengue forecasting:
comparing random forests and artificial neural networks for predicting
dengue burdens at the national and sub-national scales in Colombia.
PLOS Neglected Tropical Diseases 14(9):e0008056.
[43] Xia Y, Greenwald Z, Milwid R,
Trottier C, Boissonnault M, Gaul N, Charest L, Landry G, Szabo J, Thomas
R, Maheu-Giroux M (2020). Pre-exposure prophylaxis
uptake among men who have sex with men who used non-occupational
post-exposure prophylaxis: a longitudinal analysis of attendees at a
large sexual health clinic in Montréal (Canada). JAIDS – Journal of
Acquired Immune Deficiency Syndromes 85(4):408-415.
[42] Doyle CM, Maheu-Giroux M,
Lambert G, Mishra S, Apelian H, Messier-Peet M, Otis J, Grace D, Hart
TA, Moore DM, Lachowsky NJ, Cox J, and the Engage Study Team (2020).
Combination HIV prevention among Montreal gay, bisexual, and other men
who have sex with men in the PrEP era: a latent class analysis. AIDS
and Behavior 25:269-283.
[41] Lanièce CD, Cox J, Klein M, Lambert G,
Grace D, Lachowsky N, and Maheu-Giroux M (2020). Trends
in HCV seroprevalence and associated risk factors among men who have sex
with men in Montréal: results from three cross-sectional surveys (2005,
2009, 2018). Sexually Transmitted Infections 97:290-296.
[40] Owen BN, Baggaley RF, Maheu-Giroux
M, Elmes J, Adimora A, Ramirez C, Edmonds A, Sosanya K, Taylor
T, Plankey M, Cederbaum J, Seidman D, Weber K, Golub E, Wells J, Bolivar
H, Konkle-Parker D, Boily MC (2020). Patterns and trajectories of anal
intercourse practice over the life course among HIV-negative US women in
the WIHS cohort. The Journal of Sexual Medicine
17(9):1629-1642.
[39] Godin A, Kronfli N, Cox J, Alary M, and
Maheu-Giroux M (2020). The role of prison-based
interventions for hepatitis C virus micro-elimination among people who
inject drugs in Montréal, Canada. International Journal of Drug
Policy 88:102738.
[38] Owen BN, Maheu-Giroux M,
Matse S, Mnisi Z, Baral S, Ketende SC, Baggaley RF, and Boily MC (2020).
Prevalence and correlates of anal intercourse among female sex workers
in eSwatini. PLOS One 15(2):e0228849.
[37] Maheu-Giroux M, Marsh K, Bhatkoti
R, Doyle CM, Godin A, Lanièce Delaunay C, Jonhson
LF, Jhan A, Abo K, Mbofana F, Boily MC, Buckeridge DL, Hankins C, and
Eaton JW (2019). National HIV testing and diagnosis coverage in
sub-Saharan Africa: a new modeling tool for estimating the “first 90”
from program and survey data. AIDS 33(Suppl 3):S295-S302.
[36] Maheu-Giroux M, Jahn A, Kalua T,
Mganga A, Eaton JW (2019). HIV surveillance based on routine testing
data from antenatal clinics in Malawi (2011-2018): measuring and
adjusting for bias from imperfect testing coverage. AIDS
33(Suppl 3):S295-S269.
[35] Greenwald ZR, Maheu-Giroux M,
Szabo J, Robin-Bérubé JA, Boissonnault M, Nguyen VK, Thomas R (2019).
Cohort Profile: l’Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study.
BMJ Open 9:e028768.
[34] Maheu-Giroux M and Castro MC
(2019). Attribution of reductions in malaria prevalence in Dar es
Salaam, Tanzania. The Lancet Planetary Health 3(6):e246.
[33] Maheu-Giroux M, Diabaté S, Boily
MC, Jean-Paul N, Vesga JF, Baral S, Abo K, Wogwin V, Diouf D, Alary M
(2019). Cost-effectiveness of accelerated HIV response scenarios in Côte
d’Ivoire. JAIDS – Journal of Acquired Immune Deficiency
Syndromes 80(5):503-512.
[32] Maheu-Giroux M and Joseph SA
(2018). Moxidectin for deworming: from trials to implementation. The
Lancet Infectious Diseases S1473-3099(18)30270-6.
[31] Tavitian-Exley I, Maheu-Giroux
M, Platt L, Heimer R, Uusküla A, Levina O, Vickerman P, and
Boily MC (2018). Differences in risk behaviors and HIV status between
primary amphetamines and opioid injectors in Estonia and Russia.
International Journal of Drug Policy 53:96-105.
[30] Tavitian-Exley I, Boily MC, Heimer R,
Uusküla A, Levina O, and Maheu-Giroux M (2018).
Polydrug use and HIV risk heterogeneity among people who inject drugs: a
latent class analysis. AIDS and Behavior 22(4):1329-1340.
[29] Maheu-Giroux M, Baral S, Vesga
JF, Diouf D, Diabaté S, Alary M, Abo K, and Boily MC (2017). Anal
intercourse among female sex workers in Côte d’Ivoire: prevalence,
frequency, determinants, and model-based estimates of its
population-level impact on HIV transmission. American Journal of
Epidemiology 187(2):287-197.
[28] Maheu-Giroux M, Vesga JF, Diabaté
S, Alary M, Baral S, Diouf D, Abo K, and Boily MC (2017).
Population-level impact of an accelerated HIV response plan to reach the
UNAIDS 90-90-90 target in Côte d’Ivoire: insights from mathematical
modeling. PLOS Medicine 14(6):e1002321.
[27] Kirakoya-Samadoulougou F, Jean K, and
Maheu-Giroux M (2017). Uptake of HIV testing in Burkina
Faso: an assessment of individual and community-level determinants.
BMC Public Health 17(1):487.
[26] Maheu-Giroux M, Vesga JF, Diabaté
S, Alary M, Baral S, Diouf D, Abo K, and Boily MC (2017). Changing
dynamics of HIV transmission in Côte d’Ivoire: modeling which key
populations acquired and transmitted HIV infections and estimating the
impact of past HIV interventions (1976-2015). JAIDS – Journal of
Acquired Immune Deficiency Syndromes 75(5):517-527.
[25] Maheu-Giroux M, Tanser F, Boily
MC, Pillay D, Joseph SA, and Bäernighausen T (2017). Determinants of
time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South
Africa. AIDS 31:1017-1024.
[24] Maheu-Giroux M (2016). Oxantel
pamoate and deworming programmes. The Lancet Infectious
Diseases 16(1):5-6.
[23] Castro MC, Maheu-Giroux M,
Chiyaka C, and Singer BH (2016). Malaria incidence rates from time
series of 2-wave panel surveys. PLOS Computational Biology
12(8):e1005065.
[22] Maheu-Giroux M, Filippi V,
Samadoulougou S, Castro MC, Maulet N, Meda N, Pouliot M, and
Kirakoya-Samadoulougou F (2016). Risk factors for vaginal fistula
symptoms in sub-Saharan Africa: a pooled analysis of national household
surveys. BMC Pregnancy and Childbirth 16(1):1-10.
[21] Joseph SA, Casapía M, Montresor A, Rahme E, Ward
BJ, Marquis GS, Pezo L, Blouin B, Maheu-Giroux M, and
Gyorkos TW (2015). The effect of deworming timing and frequency on
growth in one-year old children living in an STH-endemic area of Peru: a
randomized controlled trial. PLOS Neglected Tropical Diseases
9(10):e0004020.
[20] Maheu-Giroux M, Filippi V,
Samadoulougou S, Castro MC, Maulet N, Meda N, and Kirakoya-Samadoulougou
F (2015). Fistula in sub-Saharan Africa – Authors’ reply. The Lancet
Global Health 3(8):e442.
[19] Maheu-Giroux M, Filippi V,
Samadoulougou S, Castro MC, Maulet N, Meda N, and Kirakoya-Samadoulougou
F (2015). Prevalence of symptoms of vaginal fistula in 19 sub-Saharan
Africa countries: a meta-analysis of national household survey data.
The Lancet Global Health 3(5):e271-e278.
[18] Joseph SA, Casapía M, Blouin B,
Maheu-Giroux M, Rahme E, and Gyorkos TW (2014). Risk
factors associated with malnutrition in one-year-old children living in
the Peruvian Amazon. PLOS Neglected Tropical Diseases
8(12):e3369.
[17] Maheu-Giroux M and Castro MC
(2014). Cost-effectiveness of larviciding for urban malaria control in
Tanzania. Malaria Journal 13(1):447. (*Highly Accessed)
[16] Maheu-Giroux M and Castro MC
(2014). Factors affecting providers’ delivery of Intermittent Preventive
Therapy for malaria in pregnancy: a five-country analysis of national
Service Provision Assessment surveys. Malaria Journal
13(1):440.
[15] Thériault FL, Maheu-Giroux M,
Blouin B, Casapía M, and Gyorkos TW (2014). Effects of a post-deworming
health hygiene education intervention on absenteeism in school-age
children of the Peruvian Amazon. PLOS Neglected Tropical
Diseases 8(8):e3007.
[14] Samadoulougou S, Maheu-Giroux M,
Kirakoya-Samadoulougou F, de Keukeleire M, Castro MC, and Robert A
(2014). Multilevel and geo-statistical modeling of malaria risk in
children of Burkina Faso. Parasites & Vectors 7(1):350.
[13] Tanser F, de Oliveira T, Maheu-Giroux
M and Baernighausen TW (2014). Concentrated HIV epidemics
within generalized ones in sub-Saharan Africa. Current Opinion in
HIV and AIDS 9(2):115-125.
[12] Gyorkos TW, Maheu-Giroux M,
Blouin B, Saavedra L, and Casapía M (2013). Efficacy of a single dose of
albendazole for soil-transmitted helminth infections in school children
of Iquitos, Peru. Revista Peruana de Medicina Experimental y Salud
Pública 30(4):601-607.
[11] Maheu-Giroux M and Castro MC
(2013). Do malaria vector control measures impact disease-related
behaviors and knowledge? Evidence from a large-scale larviciding
intervention in Tanzania. Malaria Journal 12:422. (*Highly
Accessed)
[10] Gyorkos TW, Maheu-Giroux M,
Blouin B, and Casapía M (2013). Impact of health education on
soil-transmitted helminth infections in schoolchildren of the Peruvian
Amazon: A cluster-randomized controlled trial. PLOS Neglected
Tropical Diseases 7(9):e2397.
[9] Maheu-Giroux M and Castro MC
(2013). Impact of community-based larviciding on the prevalence of
malaria infection in Dar es Salaam, Tanzania. PLOS One
8(8):e71638.
[8] Blouin B, Penny ME, Maheu-Giroux
M, Casapía M, Aguilar E, Silva H, Creed-Kanashiro H, Joseph SA,
Gagnon A, Rahme E, and Gyorkos TW (2013). Timing of umbilical cord
clamping and infant anemia: the role of maternal anemia. Paediatrics
& International Child Health 33(2):79-85.
[7] Gyorkos TW, Maheu-Giroux M, Blouin
B, Creed-Kanashiro H, Casapía M, Aguilar E, Silva H, Joseph SA, and
Penny ME (2012). A hospital policy change toward delayed cord clamping
is effective in improving hemoglobin levels and anemia status of
8-month-old Peruvian infants. Journal of Tropical Pediatrics
58(6):435-440.
[6] Blouin B, Penny ME, Casapía M, Aguilar E, Silva H,
Joseph SA, Creed-Kanashiro H, Maheu-Giroux M, and
Gyorkos TW (2011). Effect of a two-component intervention to change
hospital practice from early to delayed umbilical cord clamping in the
Peruvian Amazon. Pan American Journal of Public Health
29(5):322-328.
[5] Gyorkos TW, Maheu-Giroux M,
Casapía M, Joseph SA, and Creed-Kanashiro H (2011). Stunting and
helminth infection in early preschool-age children in a resource-poor
community in the Amazon lowlands of Peru. Transactions of the Royal
Society for Tropical Medicine & Hygiene 105(4):204-208.
[4] Maheu-Giroux M, Casapía M, and
Gyorkos TW (2011). On the validity of self-reports and indirect reports
to ascertain malaria prevalence in settings of hypoendemicity.
Social Science & Medicine 72(5):635-640.
[3] Maheu-Giroux M, Sotto-Calle VE,
Casapía M, Berrang-Ford L, Buckeridge DL, Coomes OT, and Gyorkos TW
(2010). Risk of malaria transmission from fish ponds in the Peruvian
Amazon. Acta Tropica 115(1-2):112-118.
[2] Maheu-Giroux M and de Blois S
(2007). The landscape ecology of Phragmites australis invasion in
networks of linear wetlands. Landscape Ecology 22(2):285-301.
[1] Maheu-Giroux M and de Blois S
(2005). Mapping the invasive species Phragmites australis in linear
wetlands corridors. Aquatic Botany 83(4):310-320.
Reports
Stansfield S, Heitner J, Mitchell K, Doyle CM, Milwid RM,
Maheu-Giroux M, Jamieson L, Meyer-Rath G, Johnson LF,
Smith J, Philips A, Boily MC, Dimitrov D (2022). Projected population
impact of expanding PrEP coverage by offering long-acting injectable
PrEP in different settings: model comparison analysis. In: Guidelines on
Long-Acting Injectable Cabotegravir for HIV Prevention. Geneva: World
Health Organization. WEB ANNEX D.
Blouin B and Maheu-Giroux M (2019). Bias assessment
and adjustments of antenatal care routine testing HIV prevalence
estimates for use to monitor epidemic trends - Protocol for estimating
spatial patterns and trends in ANC HIV prevalence, adjusting for
variation in coverage and completeness. Report submitted to UNAIDS. 62
pages.
Maheu-Giroux M (2017). A Bayesian framework for
global, regional, and national estimates of violence against women
statistics. Reported submitted to the World Health Organization, Dept.
of Reproductive Health and Research. 88 pages.
Diabaté S, Maheu-Giroux M, Vesga JF, Boily MC, and
Alary M (2015). Plan d’accélération de la réponse nationale au VIH en
Côte d’Ivoire. Rapport présenté à ONUSIDA – Région d’Afrique de l’ouest
et du centre. 145 pages.
Maheu-Giroux M and Belvisi J (2007). Volet
Biodiversité de l’Initiative Nationale d’Élaboration de Normes
Agroenvironnementales - Démarche d’appui au développement de normes
appliquées au projet pilote de l’écorégion des basses-terres du
Saint-Laurent. Rapport présenté à Environnement Canada – INÉNA. 245
pages.
Maheu-Giroux M, de Blois S, and Jobin B (2006).
Suivi des habitats et des pressions anthropiques de quatre Réserves
nationales de faune du Québec et leur périphérie à l’échelle du paysage.
Environnement Canada, Service canadien de la faune, Région du Québec. 63
p. + annexes.
Maheu-Giroux M, Boivin P, Brisson J, de Blois S, and
Bouchard A (2003). Évaluation de la résistance de différents mélanges
d’espèces végétales à l’envahissement d’espèces arborescentes >
Protocole expérimental. Institut de Recherche en Biologie Végétale -
Université de Montréal. 25 pages.